The carboprost tromethamine market, valued at USD 1.6 billion in 2023, is expected to experience steady growth in the coming years. Market projections indicate a CAGR of 3.40% between 2024 and 2032, with the market size reaching an estimated USD 2.09 billion by 2032. This growth is fueled by several factors, including rising awareness of postpartum haemorrhage (PPH) risks, the...
English
Arabic
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian